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Optimal insulin secretion required to maintain glu-
cose homeostasis is the summation of total pancre-
atic islet b cell mass and intrinsic secretory capacity
of individual b cells, which are regulated by distinct
mechanisms that could be amplified by glucagon-
like-peptide-1 (GLP-1). Because of these actions of
GLP-1 on islet b cells, GLP-1 has been deployed
to treat diabetes. We employed SNARE protein
VAMP8-null mice to demonstrate that VAMP8 medi-
ates insulin granule recruitment to the plasma mem-
brane, which partly accounts for GLP-1 potentiation
of glucose-stimulated insulin secretion. VAMP8-null
mice also exhibited increased islet b cell mass from
increased b cell mitosis, with b cell proliferative
activity greatly amplified by GLP-1. Thus, despite
the b cell exocytotic defect, VAMP8-null mice have
an increased total insulin secretory capacity, which
improved glucose homeostasis. We conclude that
these VAMP8-mediated events partly underlie the
therapeutic actions of GLP-1 on insulin secretion
and b cell growth.
INTRODUCTION
Diabetes is a disease in which pancreatic islet b cells’ insulin
secretory capacity eventually fails to meet glycemic demand, re-
sulting in poor glucose homeostasis that leads to acute and
chronic complications (Kahn, 1998). Great efforts have thus
been directed at elucidating underlying disease mechanisms
toward clever strategies to rescue the defective glucose-stimu-
lated insulin secretion (GSIS) and/or increase b cell growth.
Glucagon-like peptides, particularly GLP-1, have become
a panacea in achieving both lofty therapeutic goals in the treat-
ment of diabetes (Lovshin and Drucker, 2009). Nonetheless,238 Cell Metabolism 16, 238–249, August 8, 2012 ª2012 Elsevier Incthe precise mechanisms by which GLP-1 influences GSIS and
b cell growth remain unclear.
Efficacious insulin secretion requires effective coupling of
agonist- (glucose, GLP-1) evoked signaling pathways to insulin
secretory granule (SG) exocytosismachineries. Amode of insulin
exocytosis is fusion of docked insulin SGs with the plasma
membrane (PM), mediated by a multimolecular complex of
fusion molecules, including SNARE (v- and t-SNAREs) and the
associated protein components (nSec/Munc18 or SM proteins,
Munc13) (Kwan and Gaisano, 2009; Su¨dhof and Rothman,
2009). Alternate modes of exocytosis include newcomer SGs
that undergo little or no docking time at the PM before fusion,
which occurs at high frequency, and SG-SG fusion after SG-
PM fusion, termed sequential exocytosis, which occurs at low
frequency in b cells (only 2%) (reviewed in Gaisano, 2012).
Both of these latter exocytotic events become substantially up-
regulated by GLP-1 to account for large portions of GLP-1-
potentiated GSIS (Kwan and Gaisano, 2005). The SM/SNARE
complex, which includes Syntaxin-1A (Syn-1A) and Munc18a,
mediates fusion of predocked insulin SGs, accounting for the
first phase of GSIS (Ohara-Imaizumi et al., 2007). The other
exocytotic proteins that mediate newcomer SGs and SG-SG
fusions remain to be defined.
VAMP8was first identified as an endosomal SNARE (endobre-
vin) involved in endosomal fusion (Antonin et al., 2000a, 2000b;
Wong et al., 1998). It was then implicated in GLUT4 exocytosis
(Zhao et al., 2009) and endocytosis (Williams and Pessin,
2008). However, VAMP8 played a nonessential role in these
membrane fusion processes because of functional redundancy
provided by other VAMPs (Antonin et al., 2000a, 2000b; Zhao
et al., 2009). In regulated exocytosis, VAMP8hasbeen implicated
in several secretory cells, including pancreatic acini (Wang et al.,
2004) and other exocrine tissues (Wang et al., 2007), platelets
(Ren et al., 2007), basophils (Lippert et al., 2007), mast cells
(Tiwari et al., 2008), lymphocytes (Loo et al., 2009), and kidney
collecting duct cells (Wang et al., 2010). For exocytosis, VAMP8
interacts robustly with SNAP23 and Syn-4 (Wang et al.,
2004, 2007, 2010) and the SM protein Munc18c (Cosen-Binker.
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Vti1b (Antonin et al., 2000a). In exocrine pancreas, VAMP8
mediates not only SG-PM exocytosis, but also SG-SG fusion,
the latter involving a distinct SM/SNARE complex that in-
cludes Munc18b, SNAP23, and Syn-3 (Cosen-Binker et al.,
2008).
In the current work, we employed VAMP8-null mice (Cosen-
Binker et al., 2008; Wang et al., 2004) to show that GLP-1-poten-
tiated islet GSISwas reduced because of deficient recruitment of
newcomer SGs to the PM and could be rescued to fully restore
biphasic GSIS by VAMP8 re-expression. Surprisingly, VAMP8-
null mice paradoxically exhibited increased b cell proliferation
and mitosis, which could be upregulated by GLP-1 to amplify
b cell mitosis. Thus, in islet b cells, VAMP8 plays dual and nonre-
dundant roles in insulin exocytosis and b cell proliferation, which
could potentially impact diabetes therapy.
RESULTS
VAMP8 Mediates GLP-1-Potentiated GSIS
VAMP8 knockout (KO) mice were backcrossed to 129SvJ for
seven generations to reduce contamination from its original
mixture with C57/BL6 background. In pancreatic islets of WT
mice (litter controls), VAMP8 was found to be in b cells but not
in a cells (Figure S1A available online), where a majority (>90%)
of VAMP8 was colocalized with insulin SGs (Figure 1A, top
panels). A minority of VAMP8 was colocalized with early endo-
somes (EEA1, Figure 1A, middle panels) and lysosomes
(LAMP1, Figure 1A, bottom panels) as previously reported (Anto-
nin et al., 2000b; Wong et al., 1998). Western blotting of islets
from litter control WT and VAMP8 KO mice confirmed the
absence of VAMP8, whereas levels of cognate and noncognate
syntaxins, SNAP25, and SMproteins were not altered by VAMP8
deletion (Figure 1B).We examined the physiologic biphasic GSIS
by employing an islet perifusion assay. There was no difference
in 16.7mMGSIS in first- (PH1, first 20min) or second- (PH2, next
20 min) phase secretion (Figure 1C). However, when islets were
pretreated with GLP-1 (10 nM, plus 150 mM IBMX) to induce
cAMP-potentiated secretion, secretory responses were reduced
by 46% at PH1 and 32% at PH2 in VAMP8 KO islets (PH1, 79 ±
19; PH2, 141 ± 13) compared to WT islets (PH1, 146 ± 4; PH2,
207 ± 13, Figure 1D). To confirm that this reduced secretory
response was attributed to VAMP8 deficiency per se, we trans-
duced VAMP8 KO islets with adenoviruses expressing VAMP8
(Ad-VAMP8-GFP, 70% transfection efficiency by GFP fluores-
cence), which fully restored PH1 (192 ± 20) and PH2 (279 ± 43)
(Figure 1E) secretion compared to Ad-GFP expression (PH1,
102 ± 6; PH2, 135 ± 24); this was an increase of 88% and
107%, respectively.
Insulin content per islet from VAMP8 KOmice was higher than
WT mice islets (Figure S1B), raising the possibility of a higher
b cell number in VAMP8 KO islets. However, in islet perifusion
assays, insulin released was always normalized to total islet
insulin content to negate such bias. Nonetheless, we assessed
the exocytotic capacity of single b cells by employing patch-
clampmembrane capacitancemeasurements (Cm) using a serial
depolarization protocol (Figure 1F), wherein the first two pulses
estimate the readily releasable pool (RRP) and succeeding
pulses (third to tenth) measure RRP refilling, postulated to corre-Celspond to PH1 and PH2 of GSIS, respectively (Rorsman and
Renstro¨m, 2003). In absence of cAMP in the patch pipette (Fig-
ure 1F), DCm in WT and VAMP8 KO b cells were comparable.
In presence of cAMP (0.1mM) and glucose (16.7mM) (Figure 1G)
to simulate GLP-1-potentiated GSIS as in the islet perifusion
study (Figure 1D), RRP (6.5 ± 0.6) and RRP refilling (18.5 ± 1.2)
were reduced in VAMP8 KO b cells by 34% and 23%, respec-
tively, compared to WT b cells (RRP, 9.8 ± 1.2; RRP refilling,
24.0 ± 2.1). To ensure that the effects of VAMP8 or its absence
are on exocytosis per se, and not due to effects on Ca2+ influx
during PM depolarization, we showed integrated Ca2+ currents
during depolarization to be similar between the two groups
(Figure 1H).
VAMP8 Recruits Newcomer Granules to Plasma
Membrane to Undergo Exocytosis
We examined how changes in single SG fusion dynamics would
account for the above secretory results by employing time-lapse
total internal reflection fluorescence microscopy (TIRFM) to
monitor exocytosis dynamics of insulin SGs tagged with neuro-
peptide Y (NPY)-EGFP by adenovirus transduction (Ad-NPY-
EGFP) ofmice b cells. At the basal unstimulated state (Figure 2A),
punctate fluorescence indicating docked SGs was not dif-
ferent between WT (10.2 ± 0.624 /100 mm2) and KO (10.4 ±
0.817 /100 mm2) b cells. When cells were stimulated with
16.7 mM glucose plus 10 nM GLP-1, the SG densities of WT
b cells examined per image serially were observed to be
increasing compared to a slight decrease from basal levels in
KO b cells (Figure S2A), which is largely contributed by a more
sustained increase in newcomer SGs toward the PM in WT
b cells. Consistently, assessment of cumulative fusion events
over time (Figure 2B) showed much less fusion events during
the 18 min stimulation in KO b cells than in WT b cells.
We then dissected the single SG fusion dynamics (Figure 2C).
At 2.8 mM glucose, either in the absence or presence of GLP-1,
we seldom found spontaneous fusion events (Figure 2D). When
16.7 mM glucose was added (after preincubation with GLP-1
plus IBMX), single SG fusion events were observed as flashes
of fluorescence that rapidly dissipate in a cloud-like diffusion
pattern. However, these exocytotic events were not uniform
from the same group of SGs, but could be categorized into three
distinct modes (Figure 2C). ‘‘Predock’’ fusion mode (Figure 2C,
top; Figure 2D, blue) refers to SGs that were already docked
onto the PM (as Figure 2A) for a period of time prior to stimula-
tion. Newcomer SGs refer to new SGs appearing de novo after
stimulation within the evanescent field that then undergo exocy-
tosis, which can be categorized into two distinct patterns (Kasai
et al., 2008; Shibasaki et al., 2007) designated as ‘‘no-dock’’ (Fig-
ure 2C, middle) and ‘‘short-dock’’ (Figure 2C, bottom) new-
comers. No-dock newcomer SGs (Figure 2D, red) are newly re-
cruited by stimulation and immediately fused with the PM (a
docking state <200 ms, minimal interval between two consecu-
tive frames). Short-dock newcomer SGs (Figure 2D, green) are
those newly recruited by stimulation that first docked for some
residence time at the PM varying from seconds to minutes and
then fused with the PM. Even in PH1 GSIS, newcomer SGs
already accounted for >70% of exocytotic events in WT b cells
(Figure 2D, top), which corresponded to the diverging cumulative
increase in exocytosis in WT b cells compared to KO cellsl Metabolism 16, 238–249, August 8, 2012 ª2012 Elsevier Inc. 239
Figure 1. VAMP8 Deletion Abolishes GLP-1-Potentiated GSIS in Pancreatic b Cells
(A) Representative immunofluorescence images of VAMP8 (red) with insulin (green), early endosomes (EEA1 antibody, green), or lysosomes (LAMP1 antibody,
green) inmouse pancreatic b cells, with their colocalization shown inmerge images (yellow). Shown are representative images of three independent experiments.
Scale bars represent 3 mm.
(B) Western blotting analysis of SNARE and SNARE-associated protein expression in pancreatic islets of WT and VAMP8 KO mice. Pancreatic acini and brain
used as positive and negative controls.
Cell Metabolism
GLP-1 Effects b Cell Secretion and Growth by VAMP8
240 Cell Metabolism 16, 238–249, August 8, 2012 ª2012 Elsevier Inc.
Figure 2. VAMP8 Mediates Exocytosis of
Newcomer Insulin Granules
(A) Left: TIRF images of docked insulin SGs in WT
or VAMP8 KO islet b cells. Scale bars represent
2 mm. Right: Comparison of averaged SG densities
before stimulation. Summary graph is shown as
means ± SEMs, not significant.
(B) Normalized cumulative fusion events of insulin
SGs per cell per 100 mm2 stimulated as indicated.
(C) Kymographs and corresponding fluorescence
intensity curves showing threemodes of insulin SG
fusion events in islet b cells: ‘‘pre-dock’’ (blue bar),
‘‘newcomer - no dock’’ (red bar), and ‘‘newcomer -
short dock’’ (green bar) (shown is 20 s docking time
before undergoing fusion). Data are shown as
means ± SEMs.
(D) Histogram of different fusion events in the the
first phase (first 5 min after 16.7 mM glucose
stimulation) and second phase (5–18 min) in WT
versus KO b cells. Data obtained from five inde-
pendent experiments (three to five cells from each
experiment; WT = 16 cells, KO = 18 cells), ex-
pressed as mean ± SEMs.
(E) Summary of the three modes of fusion events in
the first (left) and second phases (right), shown as
means ± SEMs. *p < 0.05, **p < 0.01.
See also Figure S2.
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analysis, Figure 2E) were similar between WT and KO b cells in
PH1 and PH2GSIS. To confirm, we assessed exocytosis evoked
by 50mMK+ stimulation, which causes fusion of predocked SGs
predominantly (68% of total fusion). There was no difference
between KO and WT b cells in fusion events of predocked SGs
occurring in the first 5 min (Figures S2B–S2D). Thus, reduction
of exocytosis in both phases of secretion evoked by 16.7 mM
glucose and GLP-1 was accounted for entirely from reduction
in newcomer SGs. In PH1 GSIS, there was reduction in only
no-dock newcomer SGs (WT 9.62 ± 1.52 versus KO 5.72 ±
0.71/100 mm2); reduction in PH2 GSIS included both no-dock
(red bars; WT, 9.78 ± 3.62 versus KO, 2.88 ± 1.13/100 mm2)(C–E) Islet perifusion assays inWT and VAMP8KOmice pancreatic islets (left), and corresponding AUCs (area
perifusion, stimulated by 16.7 mM glucose only (C), GLP-1 (10 nM) plus IBMX (150 mM) with 16.7 mM glucose
islets infected with Ad-VAMP8 or Ad-GFP (E). n = 4–5 per group. Summary graphs shown as means ± SEM
(F and G) Changes in cell Cm (DCm) in response to trains of 500 ms depolarization pulses in WT and VAMP8
normalized to basal cellCm (in fF/pF) evoked by depolarizations alone (F) (KO, n = 32;WT, n = 35) or with 16.7
n = 70). Right: Summary ofCmevoked by the first two pulses (pulses 1–2), last eight pulses (pulses 3–10), and a
as means ± SEMs. *p < 0.05.
(H) Summary of integrated Ca2+ currents (QCa) evoked by depolarization pulses from 70 to 0 mV (n =
means ± SEMs, not significant.
See also Figure S1.
Cell Metabolism 16, 238–24and short-dock (green bars; WT 5.71 ±
1.69 versus KO 1.51 ± 1.02/100 mm2)
newcomer SGs (summary analysis, Fig-
ure 2E). These results taken together indi-
cate that VAMP8 mediated the recruit-
ment and exocytotic fusion of newcomer
SGs, but not of previously docked SGs.
We probed for SM/SNARE complexes
that might mediate these distinct exocy-totic events, including newcomer SGs and predock SG fusion.
We immunoprecipitated (IPed) three major exocytotic Syntaxins
(Syn-1, Sn-2, and Syn-3) from INS-1 cells at basal (0.8 mM
glucose, Figures 3A and 3B), high-glucose (16.7 mM glucose
only, Figure 3B), and maximal (GLP-1 potentiated) stimulated
conditions (16.7 mM glucose plus 10 nM GLP-1 with IBMX,
Figures 3A and 3B) and examined which cognate SNAREs and
SM protein partners were co-IPed. The INS-1 cell line was used
to provide more abundant protein than islets required for IP
assays. As predicted, under basal conditions, Syn-1A, known to
mediate fusion of docked SGs, co-IPed Munc18a but minimal
SNAP25 and VAMP2; in high-glucose stimulation and more so
under GLP-1/IBMX potentiation, Syn-1A also co-IPed abundantunder the curve) of insulin release (right) during islet
(D), or GLP-1 plus IBMX with glucose in VAMP8 KO
s. *p < 0.05.
KO b cells. Left: Representative recordings of DCm
mMglucose and 0.1mM cAMP (G) (KO, n = 64;WT,
ll ten pulses (pulses 1–10). Summary graphs shown
11–12 per group). Summary graph is shown as
9, August 8, 2012 ª2012 Elsevier Inc. 241
Figure 3. VAMP8 Preferably Binds to Syn-3
or Syn-2 but Not Syn-1 in Forming SNARE
Complexes
(A) Co-IP assays showing Syntaxin 1A, 2 and 3
formed SM/trans-SNARE complexes in INS-1
cells after stimulation.
(B) Western blots shows co-IP of Syn-2 (left) or
Syn-3 (right) with indicated SNARE/SM proteins in
control or VAMP8 siRNA-transduced INS-1 cells,
treated as indicated. Scrambled nonsense siRNA
was transduced as controls. Syn-1A co-IP was
also performed, as shown in Figure S3C.
Studies in (A) and (B) are each representative of
three independent experiments with samples
performed in duplicate; statistical analysis is in
Figure S3D. Input controls in Figure S3B showed
no changes in levels of total lysate proteins.
See also Figure S3.
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(Figures 3A, S3C, and S3D). Syn-2 and Syn-3 co-IPed abundant
Munc18b at basal condition; in high-glucose stimulation and
more so under GLP-1/IBMX potentiation, Syn-2 and Syn-3 also
co-IPed abundant SNAP25, SNAP23, and VAMP8 (Figures 3A
and 3B). While Syn-2 and Syn-3 also co-IPed VAMP2, Syn-2
preferred VAMP2, and Syn-3 preferred VAMP8. Amounts of SM/
SNARE complexes precipitated were notably more after GLP-1-
potentiatedGSIS thanafterhigh-glucosestimulation (FigureS3D).
These SM-SNARE complexes formed by Syn-2 and Syn-3 are
reminiscent of our recent report in pancreatic acini, in which
similar SNARE/SM complexes were co-IPed (Cosen-Binker
et al., 2008). In that report, we postulated that Syn-2/VAMP2/
SNAP23/Munc8b mediated SG exocytosis with apical PM and
that Syn-3/VAMP8/SNAP23/Munc18b mediated SG-SG fusion.
We next investigated whether formation of SM/SNARE
complexes could be altered by depletion of VAMP8. Expression
of endogenous levels of VAMP8 in INS-1 was reduced by 88.2%
by small interfering RNA (siRNA) treatment (compared to scram-
bled siRNA), which caused reduced amounts of SNAP25 and
SNAP23 to be co-IPed by Syn-2 and Syn-3, with no influence
on VAMP2 (Figure 3B). This suggests that VAMP8 depletion
negatively affected the stability of Munc18b/Syn-3 and Syn-2
complex with SNAP25 and SNAP23. VAMP8 may thus mediate
newcomer SG fusion with the PM by its interactions with Syn-3
or Syn-2.While not assessed in our TIRFM study, a small amount
of SG-SG fusion occurs in b cells, better assessed by two-
photon microscopy (Takahashi et al., 2002, 2004) and reported
to be also amplified by GLP-1 potentiation (Kwan and Gaisano,
2005), and it may be mediated by one of these SM/SNARE
complexes as postulated for pancreatic acini (Cosen-Binker
et al., 2008). SNAP23 might play a redundant role to SNAP25
(Sadoul et al., 1997), but its precise role in insulin exocytosis
has not been determined. Syn-1A SM-SNARE complexes (Fig-
ure S3C) were not at all altered by VAMP8 depletion, thus
enabling fusion of predocked SGs (Figures S2B–S2D).242 Cell Metabolism 16, 238–249, August 8, 2012 ª2012 Elsevier Inc.VAMP8 Deletion Paradoxically
Increases b Cell Mass
Reduction of individual b cell insulin
exocytosis by VAMP8 deletion (Figures1 and 2) would be expected to reduce overall in vivo insulin
secretory capacity, which would result in abnormal glucose
homeostasis. We thus proceeded to conduct an intraperitoneal
(i.p.) glucose tolerance test (IPGTT) to confirm this. Very surpris-
ingly, VAMP8 KO mice exhibited a paradoxical response of
better glucose tolerance than WT mice (Figure 4A). In fact,
plasma insulin collected during IPGTT showed correspondingly
higher insulin levels in KO mice versus WT mice (Figure 4B, cor-
responding area under the curve [AUC] shown on the right).
During the preparation of this work, a report employing VAMP8
KO mice on a mixed but predominant C57/BL6 insulin resis-
tance-prone background showed that VAMP8 deletion in-
creased sarcolemmal GLUT4 levels, thus improving insulin
sensitivity (Zong et al., 2011). We thus performed insulin toler-
ance tests and found that our VAMP8 KO mice on a dominant
129SvJ background exhibit comparable insulin sensitivity in
peripheral tissues between VAMP8 KO andWTmice (Figure 4C),
suggesting that differences in insulin sensitivity between the two
studies were in part accounted for by differences in genetic
background.
Since VAMP8 influenced b cell secretion, it’s possible that
global VAMP8 deletion could also alter intestinal L cell secretion
of incretin hormones, GLP-1, and gastric inhibitory polypeptide
(GIP), which could in turn potentiate GSIS (and b cell growth—
see below). We thus examined GLP-1 and GIP secretion in
response to oral GTT (OGTT). Basal and peak plasma levels of
total GLP-1 and GIP were similar betweenWT and KOmice (Fig-
ure 4D); the better glucose tolerance and higher insulin levels in
KO mice were confirmed (Figures S4A and S4B).
Thus, the next plausible explanation for the apparent discrep-
ancy between reduced exocytosis of individual VAMP8 KO
b cells and higher in vivo insulin secretion would be that
VAMP8 KO mice might have increased b cell mass whereby
a much large number of b cells could collectively secrete more
insulin in vivo. We examined the islet mass in infant (2-week-
old) and adult (6- to 12-week-old) mice. Islets of 2-week-old
Figure 4. VAMP8 Deletion Caused an
Increase in Islet b Cell Mass, which
Improved Glucose Homeostasis
(A, B, I, and J) IPGTTs were performed without
(A and B) or with (I and J) 30 min Ex-4 pretreat-
ment, with blood glucose levels (A and I) and
insulin secretion (B and J) assessed during IPGTT.
Insulin secretion is also shown as AUC encom-
passing 120 min of IPGTT (right panels). n = 10 for
each group.
(C) Blood glucose levels during IPITT. n = 8 for
each group.
(D) OGTTs preformed on age-matched male mice
and circulating levels of total GLP-1 (left) and GIP
immunoreactivity (right) were measured before
and after oral glucose administration. Corre-
sponding levels of blood glucose and insulin are
shown in Figures S4A and S4B, respectively. n =
10 for each group. Summary graphs shown as
means ± SEMs.
(E–H) VAMP8 deletion leads to increased b cell
area and proliferation.
(E) Insulin-immunostained pancreatic sections
(left). Scale bars represent 200 mm; b cell area per
pancreatic area ratios on 2-week-old (middle) or 6-
to 12-week-old (right) mouse pancreatic sections.
(F) Islet architecture shown in Ki67-stained
pancreatic sections (white arrows indicate Ki67-
positive signals) (left). Scale bars represent 20 mm;
Ki67-positive islet b cells as percentage of total
islet b cells on 2-week-old (middle) or 6- to 12-
week-old (right) mouse pancreatic sections are
shown.
(G) Islet numbers per total pancreas area.
(H) Islet architecture shown as insulin (red) and
glucagon (green) staining on pancreatic sections.
Scale bars represent 40 mm.
Results are shown as means ± SEMs, n = 10–11
mice for each. *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S4.
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already displayed increased b cell proliferative activity indi-
cated by a larger number of Ki67-positive b cells (Figure 4F,
middle, and Figure S4C). In contrast, 6- to 12-week-old
VAMP8 KO islets at basal condition showed an increase in
b cell area per pancreatic area (Figure 4E, left and right) along
with increased percentage of Ki67-positive b cells in KO mice
versus WT mice (Figure 4F, left and right, and Figure S4D).
There were no changes in the number of islets (Figure 4G).
Taken together, these results suggest that VAMP8 regulates
b cell proliferation shortly after birth rather than the formation
of new b cells that would have otherwise increased isletCell Metabolism 16, 238–24number (Dor et al., 2004). There is also
no change in size of b cells from WT
or VAMP8 KO mice, as estimated by
whole-cell capacitance (WT, 7.8 ± 0.3
pF, 131 cells; KO, 7.3 ± 0.3 pF, 127 cells;
not significant). Insulin and glucagon
double immunostaining showed intact
islet architecture in KO mice similar to
WT islets, suggesting that VAMP8 doesnot play a role in organization of different islet cell subsets
(Figure 4H).
We then examined whether the increased mass of b cells in
VAMP8 KO mice would be responsive to clinically used long-
acting GLP-1 analog exendin-4 (Ex-4) in potentiating GSIS
in vivo. VAMP8 KO mice pretreated with Ex-4 followed by i.p.
glucose stimulation exhibited only a similar potentiated increase
in plasma insulin release (although earlier peak) as WTmice (Fig-
ure 4J), thus attaining similar blood glucose levels (Figure 4I).
These results indicate that the smaller islet b cell mass in WT
mice has similar maximal insulin secretory capacity as the larger
KO b cell mass, suggesting that maximal insulin secretory9, August 8, 2012 ª2012 Elsevier Inc. 243
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GLP-1 Effects b Cell Secretion and Growth by VAMP8capacity of individual b cells from VAMP8 KO mice islets would
have to be reduced, consistent with the in vitro results in Figures
1 and 2. These results suggest that GLP-1-potentiated GSIS is
primarily mediated by VAMP8 and that defect in exocytosis in
VAMP8 KO b cells is overcome by the increased b cell mass.
VAMP8 KO Amplifies GLP-1/Ex-4-Induced b Cell
Proliferation
Increased b cell mass in VAMP8 KO islets could be due to
primary or secondary effects, including insulin secretory defi-
ciency and peripheral insulin resistance leading to compensa-
tory b cell proliferation (Kahn, 1998). The latter seems unlikely
since VAMP8 KO mice assessed by insulin tolerance test were
not insulin resistant (Figure 4C). In Figure 4D, we have shown
that plasma incretin levels that could affect islet mass were not
altered.
We thus postulated that VAMP8 affects b cell proliferation by
a mechanism distinct from its actions on the exocytotic
machinery. We examined factors in VAMP8 KO islets that could
account for b cell proliferation, including Pdx1, a critical tran-
scription factor for b cell proliferation and survival (WT, 100%;
VAMP8 KO, 172% ± 19.4%), and cell-cycle protein cyclin D1,
a mediator for b cell proliferation (WT, 100%; VAMP8 KO,
150.3% ± 10.5%), which were at higher levels in VAMP8 KO
than WT islets at basal conditions (Figure 5A). There has been
much ado about GLP-1-based therapies that increase islet
b cell mass in diabetes patients (Lovshin and Drucker, 2009).
To assess whether VAMP8 KO deletion might induce islet b cells
to become more conducive to Ex-4-induced proliferation, we
examined the in vivo effects of Ex-4 on b cell mass. VAMP8
KO and WT mice were treated twice daily with Ex-4 injections
for three consecutive days, and on the fourth day pancreata
were isolated and subjected to several assays: islet isolation
for western blot analysis, and pancreatic tissue sectioning for
islet morphometry and histochemical analysis. Ex-4 treatment
caused the already higher basal levels of cyclin D1 to increase
by a 477% in VAMP8 KO islets compared to a lower 226%
increase in WT islets (Figure 5B). Pdx1 levels were mildly
increased in VAMP8 KO (from 152% to 264%) and WT islets
(from 100% to 165%). Ex-4 treatment caused a stronger
85% increase in b cell area in KO islets (Figure 5C; WT,
0.0052 ± 0.0006; KO, 0.0096 ± 0.0017; p < 0.05). With already
higher basal levels of Ki67 in VAMP8 KO islets (WT, 0.38% ±
0.05%; KO, 0.88% ± 0.16%; Figure 4F), Ex-4 caused a higher
increase of 186% in Ki67 levels (Figure 5D, brown colored cells
in Figure 5E) in VAMP8 KO islets (2.52% ± 0.55%; p < 0.05)
versus 145% increase in WT islets (WT, 0.93 ± 0.13%, p <
0.05). To assess whether Ex-4 treatment per se caused these
increases beyond those attributed to the VAMP8 genotype, we
analyzed the data as the ratio of KO/WT and fold increase (Table
S1), which showed that Ex-4 per se increasedmore so in VAMP8
KO than in WT islet b cell area, Ki67, and cyclin D1 levels but
not Pdx1.
Polo-like kinase 1 (Plk1), an activator of several stages in
mitosis, particularly centriole activity (Tsou et al., 2009), was
more abundant in islets within VAMP8 KO mouse pancreas
sections (Figure 5F), which was confirmed at protein level by
isolation of the islets after in vivo Ex-4 treatment. Here, basal islet
levels of Plk1 (Figure 5G) were already higher in VAMP8 KO islets244 Cell Metabolism 16, 238–249, August 8, 2012 ª2012 Elsevier Inc(KO, 269%; WT, designated as 100%). Ex-4 treatment caused
a 229.8% increase in islet Plk1 protein levels in VAMP8 KO islets
(886.4% of WT basal levels) compared to very little increase of
21.7% inWT islets (121.7%). Apoptotic processes seemed unal-
tered by VAMP8 deletion as islet levels of total caspase 3 and
cleaved (activated) caspase 3 were not different between
VAMP8 KO and WT islets (data not shown).
Because of the possibility of unforeseen confounding in vivo
factors that can account for b cell proliferation, mouse islets
were isolated and treated ex vivo with Ex-4 for 48 hr and
dispersed into single b cells for imaging analysis of Plk1 and
BrdU incorporation. Ex-4 caused basal Plk1 activity (Figure 5H)
in VAMP8 KO b cells (4.26 ± 0.57, similar to 3.5 ± 0.26 in WT
b cells) to increase by 239% (14.43 ± 0.63) which was higher
(p = 0.03) than the 134% increase in WT b cells (8.27 ± 0.85).
BrdU incorporation (indicator of active DNA replication, Fig-
ure 5I), although similar between VAMP8 KO and WT b cells at
basal condition (12.02 ± 0.85 versus 6.73 ± 2.79 in WT b cells,
p = 0.07), Ex-4 caused a much larger increase of 307% in
VAMP8 KO b cells (48.88 ± 2.62, p = 0.02) compared to 181%
increase in WT b cells (18.94 ± 3.44).
These results taken together indicate that VAMP8 deletion per
se was the primary driver of increased b cell growth, which was
amplified further by GLP1/Ex-4 treatment.
VAMP8 Depletion Enhances b Cell Mitosis
VAMP8 actions on b cell proliferation are likely mediated by
mechanisms distinct from that directly affecting insulin exocy-
tosis. In fact, several reports showed that VAMP8 is localized
to the midbody during midbody abscission in cell division to
daughter cells, whereby dominant-negative VAMP8 (Low et al.,
2003) or siRNA downregulation of VAMP8 expression (Schiel
et al., 2011) blocked midbody abscission. These studies were
nonetheless performed on cell lines (MDCK, HeLa cells). It was
thus opportune to examine the possible role of VAMP8 in islet
b cell mitosis, employing VAMP8 KO islet b cells (Figures 6D
and 6E) and siRNA downregulation of VAMP8 expression in
INS-1 cells (Figures 6B and 6C) in response to Ex-4-induced
proliferation. We assessed the distribution of a-tubulin (green)
as a marker for microtubules (Figure 6), which exhibit different
patterns of web-like cytosolic distribution during the stages of
mitosis (Figures 6A, 6B, and 6D approximate the mitotic stages
depicted in the cartoons). In 10 nM Ex- (16–24 hr) treated control
INS-1 cells (Figure 6A), as expected (Low et al., 2003; Schiel
et al., 2011), VAMP8 (red) accumulated at sites of microtubule
concentration (yellow, merge images) within mitotic structures
(top to bottom: metaphase, anaphase, telophase). In telophase,
microtubules appear to concentrate at intercellular bridges of
narrowing cleavage furrows between dividing daughter cells
(Figure 6B, third image; Figure 6C, bottom); this is precisely
where VAMP8 is located in control cells (Figure 6A, bottom).
Remarkably, VAMP8 siRNA-treated INS-1 cells (88.2% knock-
down, Figures 6B and 6C) showed a higher percentage (4.6-
fold) of mitosis (5.48% ± 0.73%) compared to scrambled
siRNA-treated INS-1 cells (1.20% ± 0.51%). Whereas WT islet
b cells have low capacity to undergo mitosis, 48 hr Ex-4
(10 nM) treatment of isolated VAMP8 KO (Figure 6D) islets
(then dispersed into single b cells) caused a much higher
percentage (3.3-fold) of mitosis (0.50% ± 0.13%) than WT b cells.
Figure 5. VAMP8 Deletion Amplifies GLP-1/Ex-4-Induced b Cell Proliferation
(A and B)Western blots identifying the indicated proteins inWT (+/+) and VAMP8 KO (/) mouse islets. In (A), n = 4. Separate experiments were done in absence
and presence of in vivo Ex-4 treatment. In (B), n = 4, with the respective densitometry analyses shown in the corresponding bottom panels. Values fromWT islets
without Ex-4 treatment were used as a control (100%), wherein all other values were normalized to the control.
(C) b cell area per pancreatic area was calculated on insulin-stained pancreatic sections in in vivo Ex-4-treated WT and VAMP8 KO mice. n = 10 mice each.
(D) Ki67-positive islet b cell, as percentage of total islet b cells, in in vivo Ex-4-treated WT and VAMP8 KO mice. n = 10 mice each.
(B–D) Additional analyses of the data in (B) (Cyclin D1, Pdx-1), (C) (b cell area), and (D) (Ki67) are in Table S1 to assess whether increases in these factors are due to
VAMP8 KO genotype or Ex-4 induction per se.
(E) Islet architecture shown by Ki67 staining on pancreatic sections (red arrows indicate Ki67-positive signals in WT; red signals indicate Ki67-positive signals in
KO). Scale bars represent 20 mm.
(F and G) VAMP8 KO pancreatic b cell exhibit increased mitotic activity.
(F) Representative immunofluorescence images of islet insulin (green) and Plk1 (red) in pancreas sections of in vivo Ex-4-treated mice. Scale bars
represent 50 mm.
(G) Western blot showing islet levels of polo-kinase 1 (Plk1) (top panel) and blot analysis (bottom panel) of four experiments.
(H and I) Representative immunofluorescence images (left panels) and summary graphs of the staining intensity (right panels) from littermate WT and VAMP8 KO
islet b cells stained for insulin (green), Plk1 (red) (H), or with BrdU incorporation (red) (I). Here, isolated islets were treated ex vivo with or without Ex-4 as indicated.
Scale bars represent 5 mm. n = 10–15 cells per group.
Summary graphs are shown as means ± SEMs. *p < 0.05, **p < 0.01; NS, not significant.
See also Table S1.
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GLP-1 Effects b Cell Secretion and Growth by VAMP8(0.15% ± 0.06%) (Figure 6E). These results indicate that VAMP8
deletion per se increases Ex-4 induction of b cell mitosis.
DISCUSSION
In this work, we have identified a dual role for VAMP8 in islet
bcells. First is VAMP8’s role in insulin SG exocytosis, which isCelby mechanisms distinct from its second role in b cell prolifera-
tion, the latter at least in part by VAMP8’s actions on mitosis.
Below we discuss these two major findings.
Our first major finding is that VAMP8 mediates recruitment of
newcomer insulin SGs to the PM, contributing to biphasic
GSIS. In spite of possessing the major exocytotic machinery
of neurons (Syn-1/Munc18a), b cell is a rather slow secretoryl Metabolism 16, 238–249, August 8, 2012 ª2012 Elsevier Inc. 245
Figure 6. VAMP8 Deletion Enhances Ex-
Induced b Cell Mitosis
(A) In INS-1 cells treated with 10 nM Ex-4, VAMP8
(red) accumulates in regions of a-tubulin (green)
concentration, the latter to identify the changes
in pattern of microtubules in different stages of
mitosis. Shown are representative images of four
independent experiments.
(B and C) INS-1 cells transduced with VAMP8
siRNA then treated with Ex-4 (10 nM, 16–24 hr)
caused a greater increase in mitosis compared to
scrambled siRNA Control.
(D and E) Single islet b cells treated with 10 nM
Ex-4 (48 hr) from VAMP8 KO mice (bottom,
showing various stages of mitosis) exhibited much
higher rate of mitosis than b cells of WT mice (top,
showing no mitosis).
Quantitative analysis (means ± SEMs) of per-
centage of mitotic structures in b cells per section
is shown in (C) from three independent experi-
ments (n = 20 sections per group) for (B), and (E)
from three independent experiments (n = 28
sections per group) for (D). *p < 0.05, **p < 0.01.
Scale bars represent 5 mm. Cartoons of stages
of mitosis are shown, corresponding to mitotic
structures shown in (B) and (D) as indicated.
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GLP-1 Effects b Cell Secretion and Growth by VAMP8cell with reduced capacity for primary exocytosis of docked SGs
compared to neurons. b cells have ability to compensate for this
inefficiency with two additional modes of exocytosis, including
recruitment of newcomer SGs and to lesser degree, SG-SG
fusion (Gaisano, 2012). Rapid recruitment of newcomer SGs
has been described by several laboratories (Kasai et al., 2008;
Shibasaki et al., 2007; Yasuda et al., 2010). In b cells, first-phase
GSIS is contributed not only by docked SGs mediated by246 Cell Metabolism 16, 238–249, August 8, 2012 ª2012 Elsevier Inc.Munc18a/Syn-1A assembly with VAMP2/
SNAP25 (Ohara-Imaizumi et al., 2007) but
also by a larger contribution from new-
comer SGs (Seino et al., 2009). It thus
seems that for exocytosis of insulin SGs
in b cells, SG docking per se is not
a prerequisite but rather a temporal
constraint for fusion with the PM (Kasai
et al., 2008). From these reports, two
populations of newcomer SGs were iden-
tified, those that undergo rapid fusion
with minimal or no docking time (we
called ‘‘no-dock’’ SGs) and those exhibit-
ing longer docking time (‘‘short-dock’’
SGs). In first-phase GSIS, the population
of short-dock SGs, whose exocytosis
was not affected by VAMP8 defi-
ciency, might share the same exocytotic
machinery as predocked SGs employ-
ing neuronal Munc18a/Syn-1A/SNAP-25
complex with VAMP2. This suggests
that newcomer SGs undergoing minimal
docking time could be mediated by
VAMP8 in complex with Syn-2, Syn-3,
or both, along with SNAP25 andMunc18b. Takahashi et al. (2010) elegantly demonstrated that
in b cells, some regions on the PM have SNARE complexes
(Syn-1A/SNAP25) preassembled enabling rapid exocytosis,
while at other regions SNARE assembly was slower which could
account for slower exocytosis. This suggests the possibility of
more rapid assembly of VAMP8-SM/SNARE complexes to
mediate rapid exocytosis of newcomer SGs. In support of this,
VAMP8 depletion reduced the stability of Syn-2 and Syn-3
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GLP-1 Effects b Cell Secretion and Growth by VAMP8assembly with SNAP25 (and SNAP23). What are the potential
facilitators of rapid SM/SNARE complex assembly? CDK5 phos-
phorylation of Munc18b was reported to induce Munc18b/
SNARE complex (Syn-3/SNAP25/VAMP2) assembly (Liu et al.,
2007). Kasai et al. (2008) suggested that Rab27a can hasten
mobility and fusion of newcomer SGs. b cell GLP-1 receptor acti-
vation acts through cAMP/PKA signaling to accelerate recruit-
ment and fusion of newcomer SGs. Although VAMP8, Syn-2,
Syn-3, or SNAP25 do not possess consensus sites for cAMP
or PKA phosphorylation (by Motif Scan search, http://scansite.
mit.edu/motifscan_id.phtml), PKA phosphorylation of snapin
might interact with these SM/SNARE complexes to augment
insulin secretion (Song et al., 2011). Perhaps GLP-1-mediated
activation of cAMP-GEF2 and PKA phosphorylation of RIM2,
shown to accelerate recruitment of newcomer SGs (Seino
et al., 2009; Shibasaki et al., 2007; Yasuda et al., 2010), may
be interacting and perhaps even drive VAMP8 SM/SNARE fusion
complex formation. This is likely, as our protocols included IBMX
that raises cAMP levels and amplified GLP-1. Homotypic SG-SG
fusion in b cells, in the form of sequential exocytosis, occurs
infrequently and contributes relatively little to biphasic GSIS
(Takahashi et al., 2002, 2004). Whether VAMP8 exocytotic com-
plexes play a role in insulin SG-SG fusion requires further study
with more-appropriate strategies, such as two-photon micros-
copy (Takahashi et al., 2002; 2004). We also do not know
whether there are actually separate subpopulations of SGs pos-
sessing different VAMPs or a single SG population containing
both VAMP2 and VAMP8 that compete for assembly with distinct
activated Munc18/Syn complexes to mediate these distinct
exocytotic events.
The secondmajor finding in this work is that VAMP8 negatively
regulates b cell proliferation, a major target that we postulated to
be b cell mitosis. VAMP8 and cognate Syntaxin 2 were postu-
lated to participate in the terminal step of cytokinesis (Low
et al., 2003), which is abscission of midbody of two daughter
cells undergoing cell division. That study employed overexpres-
sion of a dominant-negative nonmembrane-anchored VAMP8
mutant, which probably blocked other VAMPs. However,
a more recent study showed that siRNA depletion of VAMP8
also blocked midbody abscission (Schiel et al., 2011) and that
VAMP8 from recycling endosomes was recruited to fuse with
the furrow membrane, particularly at telophase. Those reports
have used cell lines (MDCK, HeLa cells). Consistently, VAMP8
is present in endosomes of islet b cells and is concentrated in
microtubule regions of b cells where they can actively regulate
mitotic cell division. However, in contrast to those reports, our
study showed that VAMP8 deletion per se promoted b cell prolif-
eration by specific actions on promoting b cell mitosis per se,
including upregulation of mitotic factors cyclin D1 and Plk1,
the latter affecting centriole activity during cell division. These
events seemed to be cell context specific since embryonic fibro-
blasts and exocrine pancreas in VAMP8 KO mice exhibited
normal cell division (Wang et al., 2004), indicating that its role
in fibroblast and acini cytokinesis could be replaced by other
VAMPs. Furthermore, VAMP8 deletion-induced increase in
b cell proliferative activity seems to occur after birth. In b cells,
we postulate that VAMP8’s role might be that of an inhibitory
v-SNARE (Varlamov et al., 2004) rather than a v-SNARE that
promotes fusion of mitotic cleavage furrow in MDCK and HeLaCelcell lines employed in previous studies. Alternatively, VAMP8
might act as a competing weaker partial agonist v-SNARE in
b cells, wherein the absence of VAMP8 removes this negative
regulation, allowing a more potent undefined v-SNARE to
promote b cell mitosis. This would provide a fine-tuning for cyto-
kinesis. GLP-1’s ability to induce b cell proliferation was ampli-
fied by VAMP8 deficiency, suggesting that GLP-1 action might
at least in part by inactivating VAMP8 during mitosis.
The precisemechanisms bywhich GLP-1 receptor signaling in
islet b cells is coupled to its many actions, particularly insulin
secretion and b cell growth, are not completely understood,
and many gaps remain in spite of the very large amount of
work and collective effort. We hope that our work has shed
some additional insight. We showed here that GLP-1 potentia-
tion of GSIS here was in part contributed to by VAMP8-mediated
recruitment of newcomer SGs to the PM. To balance its secre-
tory function, perhaps to avoid a hypersecretory state that would
be deleterious for glucose homeostasis, VAMP8 may execute
a negative block on b cell proliferation. These two VAMP8-medi-
ated apparently opposing events affected by distinct mecha-
nisms, may underlie some of the therapeutic actions of GLP-1
on insulin secretion and b cell growth. It will be interesting to
examine whether levels or modification of VAMP8 interactions
with cognate exocytotic proteins are regulated by physiological
or pathological (T2DM) perturbation. It is envisioned that lower
levels of VAMP8may induce b cell proliferation, and higher levels
may restrict b cells to a lower basal proliferative rate, conferring
an important fine-tuning regulatory role for VAMP8 as an inhibi-
tory SNARE (Varlamov et al., 2004) on b cell mitosis. The inherent
secretory inefficiency of b cells is further accentuated in T2DM
in part by reduction in islet levels of the synaptic exocytotic
machinery (Munc18a/Syn-1A/SNAP25/VAMP2) (Ostenson et al.,
2006) that mediates exocytosis of docked SGs. This b cell secre-
tory inefficiency could be compensated by the VAMP8 exocy-
totic machinery, which recruits a large population of newcomer
SGs exceeding the population of docked SGs. In sum, we
have demonstrated a dual role of VAMP8 on exocytosis and
mitosis in b cells.EXPERIMENTAL PROCEDURES
Mouse Genetics and Islet Isolation
VAMP8 KO mice were generated and backcrossed seven generations in
129SvJ background as previously described (Wang et al., 2004, 2007). Geno-
typing was performed as reported (Wang et al., 2004). All analyses in this paper
on constitutive KO mice were performed with age-matched littermate control
(WT mice). Animal procedures were performed in accordance with the Univer-
sity of Toronto’s Animal Care Committee’s ethical guidelines. Islets were
prepared as previously described (Kwan and Gaisano, 2005).
Western Blotting and Immunoprecipitation Assay
Western blots of islet lysate samples were performed with the indicated anti-
bodies as detailed in the Supplemental Experimental Procedures. Immunopre-
cipitation assays using Syn-1, Syn-2, and Syn-3 antibodies were conducted
on INS-1 cells as also described in detail in the Supplemental Experimental
Procedures.
Islet Perifusion Assay
Batches of 50 mouse islets were stimulated with glucose in the presence or
absence of 10 nM GLP-1 (7–36) amide plus 3-isobutyl-1-methylxanthine
(IBMX; 150 mM) as previously reported (Kwan et al., 2007), with secreted insulinl Metabolism 16, 238–249, August 8, 2012 ª2012 Elsevier Inc. 247
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GLP-1 Effects b Cell Secretion and Growth by VAMP8determined by RIA (Linco Research). Insulin secreted was normalized to total
insulin content.
Confocal Immunofluorescence Microscopy
This was performed as described in the Supplemental Experimental Proce-
dures with a laser-scanning confocal imaging system (LSM510, Carl Zeiss),
and image analysis performed by NIS-Elements AR 3.0 (Nikon).
Electrophysiology
Cells were patch-clamped in conventional whole-cell configuration as
described in the Supplemental Experimental Procedures. Cm measurements
performed with an EPC-9 amplifier and PULSE software (HEKA Electronik) as
described (Kwan et al., 2007) and data analyzed with Igor Pro software
(WaveMetrics).
TIRF Imaging and Data Analysis
TIRFM images were acquired by a Nikon TE2000U TIRF microscope at 5 Hz
with a 100 ms exposure time. Insulin SG mobilization and exocytosis were
analyzed byMatlab (MathWorks), ImageJ (NIH), and Igor Pro software. Further
information about the TIRF microscopy configuration, TIRFM imaging, single-
SG exocytosis, and analysis are detailed in the Supplemental Experimental
Procedures.
Exendin-4 Treatments, IPGTT, IPITT, and OGTT
Synthetic exendin-4 (Bachem) was administered to 6- to 8-week-old mice by
i.p. injection twice daily for three consecutive days at a dose of 24 nmol/kg
body weight. Age-matched PBS-injected mice were used as controls.
Pancreases were excised and analyzed as described below. IPGTT, IPITT,
and OGTT were performed as described in the Supplemental Experimental
Procedures.
Islet Morphometry, Immunohistochemistry, and
Immunofluorescence Assay
Sections (7 mm thick) were obtained as described previously (Choi et al., 2010),
immunostained for insulin, Ki67 (DAKO), and glucagon (NovoCastra Laborato-
ries). Total b cell area, islet number, and total pancreatic area were determined
on insulin-stained sections. Total b cell area, total islet number, and Ki67 anal-
ysis were calculated per total pancreatic area. Immunofluorescence-stained
sections were visualized with a Zeiss inverted fluorescence microscope.
Statistical Analysis
All data are presented as means ± SEM. Statistical significance was
assessed by repeated-measure ANOVA, or Student’s t test in SigmaStat
(Systat Software). Significant difference is indicated by asterisks (*p < 0.05,
**p < 0.01, ***p < 0.001).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2012.07.001.
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